STUDY OF ALLERGIZING ACTIVITY OF THE DRUG «NETINFLA №2»

Authors

  • M.S. Khikmatova Tashkent pharmaceutical institute, Tashkent, Republic of Uzbekistan Author

Abstract

Successful introduction of new medicines into clinical practice presupposes the proven safety of their use. For this purpose, it is important to conduct preclinical pilot studies. Scientific methods are used to assess and prove the safety of drugs, as a requisite for the use of new drugs created for the first time in humans is previous conduct of toxicological studies on laboratory animals. One of the necessary toxicological studies is the study of allergizing activity

Published

2024-06-30

Issue

Vol. 4 No. 6 (Special Issue) (2024): Eurasian Journal of Medical and Natural Sciences

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

STUDY OF ALLERGIZING ACTIVITY OF THE DRUG «NETINFLA №2». (2024). Eurasian Journal of Medical and Natural Sciences, 4(6 (Special Issue), 424-425. https://in-academy.uz/index.php/EJMNS/article/view/10638